Clinical Trial Update: A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a Pfizer sumatriptan auto-injector for acute migraine treatment has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan Auto-Injector (sumatriptan)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 3 | Status: COMPLETED